Related Experiment Video
Updated: Jun 5, 2026

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
Diagnosing emerging and reemerging infectious diseases: the pivotal role of the pathologist
1Department of Pathology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-0428, USA. jolano@utmb.edu
Context:
Molecular diagnostics continues to evolve very rapidly, and its impact in the diagnosis of infectious diseases is undeniable. Molecular tools have played a pivotal role in discovering and characterizing several emerging infectious agents and have now become the gold standard for the diagnosis of infectious diseases caused by fastidious or uncultivable agents. Multiple challenges still remain for the widespread use of cost-effective, validated, and commercially available molecular tools. Automated instruments capable of sample processing and multiplex nucleic acid amplification and postamplification analysis have already been approved by the US Food and Drug Administration (FDA) for use in the clinical setting. Nanobiotechnology is beginning to impact laboratory diagnostics in the clinical setting.
Objective:
To address current nucleic acid techniques used in the clinical laboratory for diagnosis of infectious diseases. FDA-approved tests are listed, as well as molecular techniques (amplification and postamplification analysis). A comprehensive list of emerging pathogens during the last 4 decades is also presented. Biosurveillance systems are discussed in the context of molecular tools. The rapidly evolving field of nanobiotechnology is briefly addressed.
Data Sources:
Original publications, major reviews, and book chapters were used to present a comprehensive, yet short, review of molecular diagnostics in infectious diseases.
Conclusions:
We will continue to witness an exponential growth of molecular techniques used for the initial diagnosis of infectious diseases. Molecular tools will also continue to have an impact on disease prognosis and response to therapeutic interventions. Automation, multiplexing, and miniaturization will continue to be driving forces in the development of new instruments.
Insights
Molecular diagnostics are revolutionizing infectious disease diagnosis, becoming the gold standard for challenging agents. Continued advancements in automation and multiplexing promise further integration into clinical settings.
Area of Science:
- Clinical diagnostics
- Molecular biology
- Infectious diseases
Background:
- Molecular diagnostics rapidly evolving, impacting infectious disease diagnosis.
- Molecular tools are the gold standard for diagnosing fastidious or uncultivable agents.
- Challenges remain in cost-effectiveness, validation, and commercial availability of molecular tools.
Purpose of the Study:
- Review current nucleic acid techniques for infectious disease diagnosis in clinical labs.
- List US Food and Drug Administration (FDA)-approved tests and molecular techniques.
- Present emerging pathogens and discuss biosurveillance and nanobiotechnology.
Main Methods:
- Comprehensive review of original publications, major reviews, and book chapters.
- Focus on molecular diagnostics in the context of infectious diseases.
- Synthesis of information on techniques, pathogens, and emerging technologies.
Main Results:
- Molecular diagnostics are essential for identifying emerging infectious agents.
- Automated instruments for sample processing and multiplex nucleic acid amplification are FDA-approved.
- Nanobiotechnology is emerging as a significant factor in laboratory diagnostics.
Conclusions:
- Expect exponential growth in molecular techniques for initial infectious disease diagnosis.
- Molecular tools will increasingly influence disease prognosis and treatment response.
- Automation, multiplexing, and miniaturization will drive future instrument development.
Related Concept Videos
Rapid Identification of Pathogens
Infectious Diseases and Their Occurrence
Steps in Outbreak Investigation
Investigation of Disease Outbreaks
Methods of Classification and Identification
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...